New expensive treatments for hepatitis C infection

JAMA. 2014 Aug 13;312(6):593-4. doi: 10.1001/jama.2014.8897.
No abstract available

MeSH terms

  • Antiviral Agents / economics*
  • Antiviral Agents / therapeutic use
  • Drug Costs*
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / economics
  • Humans
  • Nucleic Acid Synthesis Inhibitors
  • Sofosbuvir
  • Uridine Monophosphate / analogs & derivatives
  • Uridine Monophosphate / economics
  • Uridine Monophosphate / therapeutic use

Substances

  • Antiviral Agents
  • Nucleic Acid Synthesis Inhibitors
  • Uridine Monophosphate
  • Sofosbuvir